Purchase Order HT001416P1091

<p>This is a firm fixed-price purchase order contract awarded by the Defense Health Agency, a defense agency, to Lifecell Corporation, a for-profit manufacturer of goods. The contract is for $32,148.00 and has an ultimate completion date of February 10, 2016. The contract is for the product STRATTICE (SP100021-039) - B.O., with no set-aside designation. The award date was February 9, 2016. Lifecell Corporation is a division of Allergan, Inc.</p>

<p>This is a federal contract award from the Defense Health Agency, a defense agency, to Lifecell Corporation, a for-profit manufacturer. The contract, worth $121,473.00, is for the delivery of STRATTICE 20X30 products. The contract is a firm fixed price purchase order with a completion date of July 14, 2015. The contract does not have a set-aside designation.</p>

This federal contract award was made by the Defense Health Agency, a defense agency, to Lifecell Corporation, a for-profit manufacturer of goods. The contract, with a ceiling value of $78,582.00, is for the procurement of 2540002-STRATTICE 25 X 40CM products. The contract type is a Blanket Purchase Agreement (BPA) Call with a Firm Fixed Price pricing structure. The place of performance is Bethesda, MD. The contract has no set-aside designation and the ultimate completion date is June 14, 2016.

<p>This is a firm fixed-price purchase order contract awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Lifecell Corporation, a division of Allergan, Inc. The contract is for the procurement of 15x30cm Strattice Surgical Mesh implants, with a ceiling value of $16,075.00 and a completion date of September 17, 2016. The contract was not set aside for any particular business type.</p>

This is a $3,438.00 firm fixed-price purchase order contract awarded by the Defense Health Agency (DHA), a defense agency, to Lifecell Corporation, a for-profit manufacturer. The contract has an ultimate completion date of April 27, 2015 and was awarded on April 24, 2015. The contract does not have a set-aside designation. Based on the contract description &quot;0608001 SP100125-302&quot;, this appears to be for the delivery of a specific product or service, though the original solicitation...

<p>This federal contract award with ID HT001416P0324 was issued by the Defense Health Agency, a defense agency, to Lifecell Corporation, a for-profit manufacturer, for $93,587.00 on a firm fixed price purchase order. The award does not have a set-aside designation. The contract is for an item described as 2040002 20X40 SP100208-010, with a completion date of December 29, 2015. No further details about the specific products or services being provided are included in the information given.</p>

This federal contract award, identified as HT001416A0071|0002, was issued by the Defense Health Agency (DHA) to Lifecell Corporation, a division of Allergan, Inc. The contract has a ceiling value of $150,000.00 and is for the procurement of INSTRUMENTS/IMPLANTS. The contract type is a BPA Call with a Firm Fixed Price pricing arrangement. The period of performance extends through September 30, 2016. This award does not utilize a set-aside. As a manufacturer of goods, Lifecell Corporation is the...

<p>This is a firm-fixed-price purchase order contract awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Lifecell Corporation, a division of Allergan, Inc. The contract is for the delivery of surgical implants and has a ceiling value of $14,720.00. The contract was awarded on January 28, 2017, with a completion date of March 30, 2017. The place of performance is Somerville, New Jersey. The contract does not have a set-aside designation.</p>

<p>This is a firm fixed-price purchase order contract awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Lifecell Corporation, a division of Allergan, Inc. The contract is for the supply of ALLODERM SELECT REGENERATIVE, SURGICAL IMPLANT, identified by the contract number N0018317P0458. The contract has a ceiling value of $57,268.00 and an ultimate completion date of March 3, 2017. This contract does not have a set-aside designation.</p>

<p>This federal contract was awarded by the Department of the Navy Bureau of Medicine and Surgery to Lifecell Corporation, a division of Allergan, Inc. The contract is for the purchase of ALLODERM UI EA QI surgical materials, with a total potential value of $135,852.00. The contract is a Firm Fixed Price Purchase Order with a completion date of June 23, 2017. There is no set-aside designation mentioned for this award.</p>